Petros Pharmaceuticals
PTPI
$0.02780
Share price
-7.33%
Change (1 day)
-93.22%
Change (1 year)
Categories
EPS for Petros Pharmaceuticals (PTPI)
EPS in 2025 (TTM): -$74.06
According to Petros Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$74.06. In 2024 the company made an earnings per share (EPS) of -$83.50 an increase over its 2023 EPS that were of -$158.75.
EPS history for Petros Pharmaceuticals from 2019 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -$74.06 | -11.31% |
| 2024 | -$83.50 | -47.4% |
| 2023 | -$158.75 | -34.4% |
| 2022 | -$242.00 | 17.33% |
| 2021 | -$206.25 | -78.57% |
| 2020 | -$962.50 | 14.96% |
| 2019 | -$837.27 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | $1.03 | -101.39% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | -$0.06000 | -99.92% | Bahamas |